Daedeok Venture Partners

Founded in 2014, Daedeok Venture Partners is a venture capital firm based in Daejeon, South Korea. The firm seeks to invest in seed to IPO stage companies operating in ICT convergence, bio-healthcare, materials, and parts sectors.

Young Choi

Partner

Jae Kap Jeong

Partner

Sung Ha Kim

Partner

Sungha Kim

Venture Partner

24 past transactions

Petnow

Series A in 2021
Operator of an artificial intelligence-based biometric identification platform intended for pet recognition via unique features like nose prints for dogs and facial recognition for cats. The company's platform gathers information about individual pets associated with corresponding owners by biometric scans of dogs and cats before being safely stored, enabling pet owners to verify their pet's identity.

LillyCover

Series A in 2021
Lillycover makes personlaized beauty solution for smart skin care by oneself. Founded in 2016, the company is headquartered in Daegu, Taegu-jikhalsi, South Korea.

Mitos.Therapeutics

Seed Round in 2021
Mitos.Therapeutics is a biotech company specializing in the development of mitochondrial-based anti-metabolic syndrome and cancer drugs.

Rocket Punch

Series B in 2021
Rocket Punch (로켓펀치) is a Korean digital marketing team that provides planning and designing services.

Petnow

Seed Round in 2020
Operator of an artificial intelligence-based biometric identification platform intended for pet recognition via unique features like nose prints for dogs and facial recognition for cats. The company's platform gathers information about individual pets associated with corresponding owners by biometric scans of dogs and cats before being safely stored, enabling pet owners to verify their pet's identity.

ILIAS

Series B in 2020
ILIAS Biologics is a biotechnology company that specializes in therapeutic molecules. The company features platform technology that enables experts to load large therapeutic molecules into exosomes. ILIAS Biologics is developing various therapeutic exosomes, a potential treatment for sepsis, pre-term birth, and various hard-to-treat diseases in inflammatory and metabolic areas.

Rocket Punch

Series A in 2018
Rocket Punch (로켓펀치) is a Korean digital marketing team that provides planning and designing services.

G2GBIO

Series A in 2018
G2GBIO is a biotechnology company focused on improving medication administration and adherence for patients with chronic diseases. The company utilizes proprietary technology to develop advanced controlled release drug products, which aim to enhance the efficacy of medications for various chronic conditions, including diabetes and cancer. By prioritizing the supply of effective medicines, G2GBIO is committed to providing patients around the world with better treatment options.

Corners

Series A in 2017
Corners invented an evacuation guide system for shooting incidents, with own emergency evacuation algorithm. It continually locates the shooter then generates the optimal action plan. The site can also be monitored externally by security and public services in real-time.

Innopresso

Venture Round in 2015
Innopresso specializes in developing innovative technologies aimed at enhancing user experience. One of its notable products is the Fusion Keyboard Mokibo, a versatile keyboard that seamlessly transitions between a conventional mechanical keyboard and a large touchpad. This design preserves the tactile feedback of mechanical typing while offering an expansive touchpad that is more than three times the size of standard notebook touchpads. The Mokibo serves multiple functions, functioning as a PC keyboard, a portable option for smart devices, and a notebook keyboard module, reflecting Innopresso's commitment to blending functionality with user-friendly design.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.